Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

Barclays logo

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

90.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 102.00
  • 52 Week Low: 53.00
  • Currency: UK Pounds
  • Shares Issued: 515.13m
  • Volume: 383,035
  • Market Cap: £463.61m
  • RiskGrade: 128
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 90.00p per share. In the last year Alliance Pharma's share price has ranged from 53.00p to 102.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 1.4% 1.6%
Div Cover 4.0 3.0
Op Mrgn 29.2% 23.0%
ROCE 85.8%  
Latest F'cast
P/E 17.2 20.4
PEG 0.4 n/a
Pr/Revenue 4.6 3.8
Pr/Book 2.3  
Latest F'cast
Revenue 6.0% 19.3%
PBT 27.7% 0.1%
EPS 38.7% -15.7%
DPS 10.0% 11.7%

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 45.28 12.01 3.82p 10.6 1.8 +6% 0.91p 2.2%
31-Dec-14 43.54 10.16 3.36p 10.9 n/a -12% 1.00p 2.7%
31-Dec-15 48.34 15.18 3.52p 12.2 2.4 +5% 1.10p 2.6%
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%
31-Dec-17 103.31 28.37 5.34p 12.6 0.3 +39% 1.33p 2.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 123.23 28.39 4.50p 20.4 n/a -16% 1.49p 1.6%
31-Dec-19 141.23 34.10 5.23p 17.6 1.1 +16% 1.60p 1.7%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Notice of Results 16-Aug-2018 07:00 RNS
Total Voting Rights 10-Aug-2018 10:00 RNS
Half Year Trading Update 25-Jul-2018 07:00 RNS

Alliance Pharma ShareCast News

Alliance Pharma on track despite currency fluctu... 25-Jul-2018 ShareCast
Alliance Pharma's morning sickness treatment gai... 06-Jul-2018 ShareCast
Alliance Pharma completes £60m Nizoral acquisition 22-Jun-2018 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 90.00p
Change Today -2.00p
% Change -2.17 %
52 Week High 102.00
52 Week Low 53.00
Volume 383,035
Shares Issued 515.13m
Market Cap £463.61m
Beta 0.00
RiskGrade 128

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
76.39% below the market average76.39% below the market average76.39% below the market average76.39% below the market average76.39% below the market average
6.25% below the sector average6.25% below the sector average6.25% below the sector average6.25% below the sector average6.25% below the sector average
Price Trend
92.78% above the market average92.78% above the market average92.78% above the market average92.78% above the market average92.78% above the market average
93.85% above the sector average93.85% above the sector average93.85% above the sector average93.85% above the sector average93.85% above the sector average
Income
61.67% below the market average61.67% below the market average61.67% below the market average61.67% below the market average61.67% below the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
Growth
80.01% above the market average80.01% above the market average80.01% above the market average80.01% above the market average80.01% above the market average
80.95% above the sector average80.95% above the sector average80.95% above the sector average80.95% above the sector average80.95% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 14-Jun-18 21-Dec-17
Paid 11-Jul-18 11-Jan-18
Amount 0.89p 0.44p

Trades for 18-Sep-2018

Time Volume / Share Price
14:36 748 @ 90.00p
14:36 45,986 @ 90.00p
14:36 45,726 @ 90.00p
14:36 85,082 @ 90.00p
14:36 115,964 @ 90.00p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page